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Abstract
Background: To evaluate the usefulness of the Holter method of sinoatrial conduction time 
(SACT) calculation in predicting the future occurrence of sinus node disease, and the emer-
gence of indications for permanent pacing in patients with unexplained syncope.
Methods: The study group included 218 patients (mean age 55 ± 17 years, 116 men) with 
syncope of unknown etiology in whom spontaneous atrial premature depolarizations (APDs) 
occurred during Holter monitoring and SACT could be calculated. A SACT value during daily 
activity > 150 ms was assumed as abnormal.
Results: The prospective observation time was 48 ± 11 months. During follow-up sinus node 
disease was diagnosed in 22 persons, including 18 patients with baseline SACT > 150 ms and 
4 with SACT < 150 ms. Indications for pacemaker implantation were found in 16 patients, 
including 13 patients with baseline SACT > 150 ms and 3 with SACT < 150 ms. In subjects 
with and without sinus node disease diagnosed during the observation period, baseline SACT 
values were 175 ± 52 ms and 87 ± 34 ms, respectively (p < 0.01), and in patients qualified and 
not qualified for permanent pacing, the respective values were 178 ± 59 ms and 81 ± 38 ms  
(p < 0.01). Multivariate Cox analysis showed a significant relationship between baseline 
SACT > 150 ms and a future diagnosis of sinus node disease and pacemaker implantation.
Conclusions: The results suggest that the Holter method of SACT calculation is useful in pre-
dicting sinus node disease and indications for permanent pacing in patients with unexplained 
syncope. (Cardiol J 2013; 20, 5: 539–544)
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Introduction
A high rate of unexplained syncope in various 
clinical settings, involving enormous resources for 
diagnosis and therapy, justifies the constant search 
for effective evaluation strategies. In most patients 
with syncope, electrocardiography (ECG) findings 
established as diagnostic [1] do not recur during 
the 24-h ECG monitoring period. Thus, the true 
yield of the standard Holter ECG assessment in an 
unselected population is as low as 1–2%. 
The sinoatrial conduction time (SACT) is the 
interval between the activation of the sinus node 
and the beginning of depolarization of the right 
atrium muscle or the P-wave beginning in an ECG. 
This time is not constant and varies throughout 
the day under the influence of the autonomic 
system; it extends during the night, and shortens 
during daytime activity [2]. The range limits are 
not definitively established. It can be assumed that 
the normal SACT usually does not exceed 150 ms 
in an awake patient. SACT measurements are 
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usually performed with various modifications of 
the Strauss’ method [3–6]. This indirect approach 
involves the introduction of progressively pre-
mature atrial depolarization during a stable sinus 
rhythm and measurement of the first return cycle. 
The measurement is taken for atrial premature 
depolarizations (APDs) falling into the reset zone, 
that is, the range of coupling intervals at which reset 
of the sinus node occurs [7]. The Holter method of 
SACT estimation is rarely used. Instead of being 
induced, it applies the spontaneous APDs recorded 
in ECG Holter monitoring during daytime activity 
[2]. One of the reasons for the low prevalence of this 
simple and noninvasive method is the lack of studies 
determining the prognostic significance of Holter 
SACT values on the basis of a prospective follow-up.
The aim of the study was to determine the 
prognostic value of SACT calculated by the Holter 
method in predicting the future diagnosis of sinus 
node disease, the occurrence of indications for 
permanent pacing and the risk of death in patients 
with unexplained syncope. 
Methods
Study population
The initial study population consisted of 300 pa- 
tients with unexplained syncope who presented 
sinus rhythm in 24-h Holter ECGs. Unexplained 
syncope was defined as a transient loss of consciou-
sness characterized by rapid onset, short duration, 
and spontaneous complete recovery whose cause 
was not established based on careful history, physi-
cal examination, standard ECG, or 24-h ECG Hol-
ter monitoring. Patients with atrioventricular block 
I–IIIo and those treated with digitalis glycoside or 
group I or III antiarrhythmic drugs according to 
the Vaughan-Williams classification were excluded. 
Finally, 218 patients (73% of the baseline 
number) in whom the Holter study showed APDs 
eligible for SACT calculation met the inclusion cri-
teria. The average age was 55 ± 17 (19–85) years. 
All of the patients were thoroughly informed 
of the study and signed a written informed consent 
form approved by the Institutional Committee on 
Human Research.
SACT calculation and follow-up 
For measurement purposes, a fragment of the 
ECG with spontaneous APD that occurred during 
daytime within a stable sinus rhythm in which the 
post-extrasystolic interval was less than the com-
pensatory length was selected (Fig. 1). The SACT 
was calculated as half the difference between the 
return cycle length after spontaneous APD (P2-P3) 
and sinus cycle length (P1-P1). 
Measurements were performed based on the 
first Holter ECG fragment with APD that fulfilled 
the following criteria:
1. APD occurred during stable sinus rhythm, 
that is, the differences in cycle length between 
3 consecutive preceding PP intervals were 
lower than 20 ms.
2. The APD coupling interval was longer than 
50% of the preceding sinus cycle length.
3. The sum of the APD coupling interval and the 
postextrasystolic pause was shorter than the 
sum of two spontaneous sinus cycle lengths.
4. APD had a positive P wave in lead CM5.
If these criteria were fulfilled, the reliability 
of SACT calculation was assumed and only one 
measurement per patient was performed.
Based on prior studies in which the Holter 
method was applied for SACT measurement, the 
value of 150 ms was taken as the optimal point of 
dichotomic distribution for prognostic purposes 
[2]. During a prospective follow-up, patients were 
subjected to clinical assessment and 24-h Holter 
monitoring in 12-month intervals. An observation 
endpoint was the patient’s death. The hospital diag-
nosis of sinus node disease and the emergence of 
indications for permanent pacing were also noted. 
These outcomes were established during follow-
-up according to the current guidelines and were 
blinded to SACT values obtained from the baseline 
24-h Holter ECG monitoring. For deaths (overall 
mortality), the date and nature were determined 
based on hospital records or information obtained 
from a patient’s family. 
Statistical analysis
SACT in different clinical groups was presen-
ted as the mean ± standard deviation. A comparison 
between the groups was performed with Student’s 
t-test or the non-parametric U Mann-Whitney test, 
Figure 1. Method of a non-invasive calculation of the 
sinoatrial conduction time.
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as appropriate. Differences in categorical data were 
tested for statistical significance with the c2 test or 
Fisher’s exact test, as appropriate. Pearson correla-
tion was used to study the association between the 
variables. The relationship between the occurrence 
of events, such as a diagnosis of sinus node disease, 
a need for permanent pacing, or death regardless 
of its cause, and clinical variables (age, gender, 
structural heart disease, and SACT > 150 ms) 
was evaluated using the logarithmic rank test. Cox 
multivariate analysis was performed by accounting 
for clinical variables (age, gender, structural heart 
disease, and SACT > 150 ms) that were significan-
tly correlated with the respective outcome in the 
univariate analysis (p < 0.05). To determine the 
most important independent variables influencing 
the outcome, results of the Wald test for individual 
parameter were examined, and the least significant 
variable that did not meet the level for staying in 
the model (p < 0.05) was removed in backward 
stepwise variable selection until the final analysis 
was reached. Statistical analysis was performed 
using the package Complete Statistical Systems 
(Microsoft Corporation, USA).
Results
The prospective follow-up duration of the 
study patients was 48 ± 11 months, the time to 
a diagnosis of sinus node disease was 26 ± 10 
months, and the time to pacemaker implantation 
was 29 ± 8 months. During the observation, 
17 patients died, including 8 (23%) with SACT 
> 150 ms and 9 (5%) with SACT < 150 ms. Sinus 
node disease was diagnosed in 22 patients, inclu-
ding 18 (51%) with SACT > 150 ms and 4 (2%) with 
SACT < 150 ms. Indications for pacemaker implan-
tation were identified in 16 patients: 13 (37%) with 
SACT > 150 ms and 3 (2%) with SACT < 150 ms. Ba-
seline clinical characteristics of patients with SACT 
values > 150 ms and < 150 ms is presented in 
Table 1 and the average values of SACT in diffe-
rent clinical groups in Table 2. Patients with SACT 
values > 150 ms were significantly older (65.7 ± 
± 9.4 vs. 53.1 ± 18.1 years; SACT > 150 ms vs. 
< 150 ms group; respectively, p < 0.0001) and 
had markedly higher prevalence of coronary artery 
disease (60% vs. 18%, SACT > 150 ms vs. < 150 ms 
group; respectively, p < 0.0001).
Univariate analysis showed a significant rela-
tionship between sinus node disease, pacemaker 
implantation and death and clinical variables, such 
as age, gender, structural heart disease, and SACT 
(Table 3). In the multivariate Cox analysis SACT 
values > 150 ms were independently associated 
with future diagnosis of sinus node disease (relative 
risk [RR] 48.3; p < 0.0001) and pacemaker im-
plantation during follow-up (RR 36.4; p < 0.0001) 
(Table 4). The only significant predictor of death 
(overall mortality) during the prospective obser-
vation was age > 60 years (RR 12.8; p = 0.014). 
Table 2. The average values of the baseline sino-
atrial conduction time (SACT) in different clinical 
groups. 
Clinical group Average  
SACT [ms]
P
Sinus node disease (+) 175 ± 52
< 0.0001
Sinus node disease (–) 87 ± 34
PM implantation (+) 178 ± 59
< 0.0001
PM implantation (–) 81 ± 38
Age ≥ 60 years 156 ± 41
< 0.0001Age < 60 years 72 ± 24
Sinus node disease (+) — occurrence of sinus node disease 
during follow-up; PM implantation (+) — occurrence of indica-
tions for pacemaker implantation during follow-up
Table 1 Baseline clinical characteristics of sinoatrial conduction time (SACT) > 150 ms and  
SACT < 150 ms patients. 
Variable SACT > 150 ms (n = 35) SACT < 150 ms (n = 183) P
Age [years] 65.7 ± 9.4 53.1 ± 18.1 < 0.0001
Age > 60 years 29 (83%) 76 (42%) < 0.0001
SACT [ms] 180.0 ± 25.0 85.0 ± 26.0 < 0.0001
Male sex 21 (60%) 95 (52%) 0.38
Structural heart disease: 30 (86%) 91 (49%) < 0.0001
Hypertension 7 (20%) 48 (26%) 0.29
Coronary artery disease 21 (60%) 33 (18%) < 0.0001
Valvular heart disease 2 (5.7%) 10 (5.4%) 0.6
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Discussion
The results of our study indicate that du-
ring the average 4-year prospective follow-up of 
patients with unexplained syncope, the baseline 
SACT values above 150 ms were associated with 
significantly increased probability of sinus node 
disease and markedly higher need for permanent 
pacing. SACT values were not associated with the 
incidence of death (overall mortality). 
During 24-h ECG Holter monitoring, the inci-
dence of spontaneous APDs in a healthy population 
ranges in various studies from 12% to 87%. In the 
majority of middle-aged and older people referred 
to the Holter test, it is possible to calculate SACT 
due to the high incidence of APDs. The basis for an 
indirect method of SACT measurement is to com-
pare the length of the first return cycle after APD 
with a basic sinus cycle length. The duration of the 
return cycle strictly depends on the conduction 
time into and out of the sinus node and on sinus au-
tomaticity. The difference between the first return 
cycle and sinus cycle length has been considered 
to be an estimate of total SACT [7]. Assuming that 
conduction time into and out of the sinus node is 
equal, half of the above-mentioned difference is 
considered as SACT. Studies comparing indirect 
Table 4. Final multivariate Cox regression models for events occurring during the follow-up: sinus 
node disease, pacemaker implantation and death. Entry variables are: age, gender, structural heart 
disease, and baseline sinoatrial conduction time (SACT) value > 150 ms. 
Wald test P RR (95% CI)
Sinus node disease (c2 = 82.3; p < 0.0001)
Structural heart disease
SACT > 150 ms
3.61
37.5
0.057
< 0.0001
3.9 (0.96–16.3)
48.3 (13.9–166.9)
Pacemaker implantation (c2 = 88.4; p < 0.0001)
Structural heart disease
SACT > 150 ms
5.63
42.38
0.018
< 0.0001
7.4 (1.4–38.9)
36.4 (12.3–107.3)
Death (c2 = 12.7; p = 0.0004)
Age > 60 years 6.1 0.014 12.8 (1.7–96.9)
CI — confidence interval; RR — relative risk
Table 3. Relationship between the occurrence of sinus node disease, pacemaker implantation, and  
death (overall mortality) during the prospective observation and the following clinical variables: age, 
gender, structural heart disease, and baseline sinoatrial conduction time (SACT) value > 150 ms.  
The results of the univariate analysis are shown.
Log-rank test P
Sinus node disease
Age > 60 years 4.2011 < 0.0001
Male gender 2.1535 0.04
Structural heart disease 4.6912 < 0.0001
SACT > 150 ms 5.9210 < 0.0001
Pacemaker implantation
Age > 60 years 2.5604 0.016
Male gender 2.3930 0.032
Structural heart disease 3.6219 0.002
SACT > 150 ms 4.9921 < 0.0001 
Death
Age > 60 years 3.9821 0.005
Male gender 2.0011 0.04
Structural heart disease 3.6302 0.007
SACT > 150 ms 2.0109 0.04
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methods of SACT measurement (both Strauss’ and 
Narula’) with directly recorded SACT have shown 
a good correlation of the results obtained from the-
se methods in patients without and with sinus node 
dysfunction [8–10]. A comparison of SACT values 
derived from 24-h Holter monitoring with SACT 
estimated by the Strauss’ method during invasive 
electrophysiological testing was also performed 
in our study in a series of 52 patients referred to 
electrophysiological testing as a part of a diagnostic 
work-up. The results from both methods are highly 
correlated (Fig. 2).
One of the most used techniques for assessing 
overall sinus node function is based on the deter-
mination of sinus node recovery time (SNRT) and 
its correction for the underlying sinus cycle length 
[7, 11]. Corrected SNRT (cSNRT) is a measure of 
the effect of overdrive pacing on both sinoatrial 
conduction and automaticity [12]. Although the 
prognostic value of a prolonged SNRT is not well 
established, the current guidelines determine its 
diagnostic role in patients with syncope, with no 
additional tests required, in sinus bradycardia and 
prolonged cSNRT > 525 ms in electrophysiologi-
cal study [1]. The prognostic significance of SACT 
may not only refer to the prediction of a sinus node 
disease associated with paroxysmal or permanent si-
noatrial blocks of II–IIIo. The results of tests carried 
out by the direct recording of sinus node potentials 
indicate that sinoatrial conduction disturbances may 
also cause an interruption of sinus rhythm, which is 
traditionally interpreted as a symptom of inhibition 
of sinus node automaticity, such as in patients with 
tachycardia-bradycardia syndrome or carotid sinus 
hypersensitivity. Asseman et al. [12] showed that 
prolonged SNRT after the cessation of rapid atrial 
pacing is more frequently caused by sinoatrial blocks 
than depressed automaticity of sinus pacing cells. 
Gang et al. [13] drew attention to the important role 
of disturbances of sinoatrial conduction in patients 
with carotid sinus hypersensitivity. Registering 
sinus node potentials during carotid sinus massage, 
these authors observed prolonged SACT directly 
before the appearance of asystole and sinoatrial 
block during asystole. 
A limitation of the Holter method is the need to 
search for APDs eligible for SACT measurement. 
In ECG fragments with a regular sinus rhythm, 
a single measurement of SACT during daytime 
is reliable [2]. When there is little variability in 
the duration of the PP interval, making several 
measurements and calculating the average values 
of SACT are justified. However, in the event of sig-
nificant arrhythmia, neither the Holter nor Strauss’ 
Figure 2. A comparison of the results of sinoatrial con-
duction time (SACT) calculation by the Straus method 
with SACT derived from Holter monitoring in 52 patients 
of the study population.
method can be applied for SACT calculation [6]. 
The autonomic nervous system is probably the 
most potent extrinsic factor modulating sinoatral 
conduction. Patients with sinus node dysfunction 
and a history suggesting vasovagal syncope have 
increased vagal activity both at rest and during 
tilting, higher heart rate variability [14] and also 
significantly increased SACT variability [15]. 
Autonomic blockade reduces SACT by Strauss’ 
method variability, which becomes comparable 
with SACT variability observed in healthy sub-
jects. Graff et al. [15] showed that patients with 
sinus node dysfunction and no history suggesting 
vasovagal syncope present distinct electrophy-
siological features. They had significantly lower 
SACT variability at basal state and higher SNRT 
and cSNRT variabilities after autonomic blockade 
in comparison with patients who had experienced 
a vasovagal syncope. Regular sinus rhythm that 
is a prerequisite for SACT calculation in Holter 
monitoring, promotes this method in evaluation 
of patients with predominant organic dysfunction 
of sinus node. In our study careful anamnesis al-
lowed to exclude patients with a typical history of 
vasovagal syncope, and moreover, Holter SACT 
values > 150 ms were obtained in patients 65.7 ± 
± 9.4 years of age, with high prevalence of coronary 
artery disease (60%). Age and a structural heart 
disease are clinical conditions that coincide with 
reduced heart rate variability what undoubtedly 
facilitates the application of the Holter method in 
SACT calculation. On the other hand impaired sino-
atrial conduction in this milieu may reflect mostly 
www.cardiologyjournal.org 543
Karol Makowski, Elżbieta Kramarz, Significance of SACT measured in Holter ECG
organic component of dysfunction. Reliability of the 
measurement and the nature of reflected abnorma-
lity in this population are probably crucial factors 
responsible for prognostic significance and a high 
correlation between SACT results obtained from 
Holter monitoring and Strauss’ method (Fig. 2). 
Nevertheless, in order to minimize the significance 
of autonomic influence on SACT, measurements 
should be performed under standardized condi-
tions during daytime [2], without the effect of 
medications or any other substance that could alter 
autonomic balance. 
Another important issue for SACT estimation 
is related to the site of origin of spontaneous or 
induced APD [7]. In our study, only the Holter elec-
trocardiograms with APDs of positive P wave direc-
tion in lead CM5 were selected. The morphology 
of the ECG recorded from this lead corresponds to 
the curve obtained from lead V5 and also partly from 
the limb lead II of a standard ECG. It seems that in 
the absence of APDs with a positive P wave in lead 
CM5, for SACT measurement purposes, premature 
contraction with a negative P wave originating 
from the inferior right or left atrium can also be 
used. Differences in SACT values determined by 
the method of stimulation of the upper and lower 
parts of the right atrium and coronary sinus area 
do not exceed 20 ms [16]. 
Perspectives
This study may have clinical implications. 
As a noninvasive and easy to perform Holter 
SACT measurement may be used as a screening 
examination to select patients with unexplained 
syncope and abnormal SACT values (> 150 ms) 
for further invasive diagnostic work-up in order to 
apply effective therapeutic options, e.g. pacemaker 
implantation, without hazardous time delay.
Conclusions
The results of our study suggest that the 
Holter method of SACT calculation is useful in pre-
dicting the future occurrence of sinus node disease 
and the need for permanent pacing in patients with 
unexplained syncope. 
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